The White House is considering options for maximizing global production and supply of Covid-19 vaccines at the lowest cost, including backing a proposed waiver of intellectual property rights, but no decision has been made, press secretary Jen Psaki said on Tuesday.
April 28, 2021 at 08:29AM
0 Comments